SARS-CoV2 infects pancreatic beta cells in vivo and induces cellular and subcellular disruptions that reflect beta cell dysfunction

Increasing evidence of new-onset diabetes during the COVID19 pandemic indicates that the SARS-CoV2 virus may drive beta-cell dysfunction leading to diabetes, but it is unclear if it is a primary or secondary effect. Here, we present evidence of SARS-CoV-2 infection of pancreatic beta cells in vivo u...

Descripción completa

Detalles Bibliográficos
Autores principales: Millette, Katelyn, Cuala, Janielle, Wang, Peiyu, Marks, Carolyn, Woo, Veronica, Hayun, Maya, Kang, Harsimar, Martin, Martin, Dhawan, Sangeeta, Chao, Lily, Fraser, Scott, Junge, Jason, Lewis, Mark, Georgia, Senta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312902/
https://www.ncbi.nlm.nih.gov/pubmed/34312617
http://dx.doi.org/10.21203/rs.3.rs-592374/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312902/
https://www.ncbi.nlm.nih.gov/pubmed/34312617
http://dx.doi.org/10.21203/rs.3.rs-592374/v1

Ejemplares similares